Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Recall

This is part of a larger recall. See all affected products.

Ongoing
Drugs
Class II — Moderate

Recall Date

Apr 22, 2026

Company

Cipla USA, Inc.

Source

FDA

Units

63,192 bottles

Reason: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Class II: Use of the product may cause temporary or medically reversible health problems.

Official FDA recall notice

Information is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.

Recall Details

Description

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Reason for Recall

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Product: Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,
Official Recall ID: FDA-DRUG-D-0451-2026
Units affected: 63,192 bottles

What Should I Do?

Check your lot number. Don't stop taking a prescribed medication without talking to your pharmacist or doctor. Contact the pharmacy where you got it about a replacement.

Quantity: 63,192 bottles

Remediation GuideAction Required

5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.

1
Confirm Your Product Is Affected
2
Read the Full Recall Notice
3
Stop Using the Product if in Doubt

+2 more steps…

View Official Recall Notice (FDA)

Last updated April 28, 2026

More recalls from Cipla USA, Inc.

Similar recalls

Injured by a recalled product?

Our legal partners offer free consultations for recall victims.

Get Free Legal Help →Sponsored

Stay Informed

Weekly recall digest — free, no spam.